Skip to Content

Management of CML in Adults: 2024 ELN Recommendations

Henrik Hjorth-Hansen, Professor, Head of Department of Hematology, St Olavs Hospital HF, Trondheim, Norway, presents the ELN recommendations. The new recommendation summarizes treatment approaches for CML, but these are not yet finalized and an overview of the discussions was presented including changes in response milestones, correct dosing of TKIs, discontinuation and a new randomized first line study of Asciminib vs Investigators choice of TKI. In this MEDtalk, Henrik Hjorth-Hansen presents some of the discussion and gives his perspective.

Henrik Hjorth-Hansen

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top